SIGMA RESEARCH SOLUTIONS LTD - Accounts to registrar (filleted) - small 18.2

REGISTERED NUMBER: 10838401 (England and Wales)

Unaudited Financial Statements

for the Year Ended 30 June 2021

for

SIGMA RESEARCH SOLUTIONS LTD

Page

Balance Sheet

1

FIXED ASSETS

2,301

2,487

CURRENT ASSETS

22,054

49,067

CREDITORS

Amounts falling due within one year

(122

)

(7,973

)

NET CURRENT ASSETS

21,932

41,094

TOTAL ASSETS LESS CURRENT LIABILITIES

24,233

43,581

CAPITAL AND RESERVES

24,233

43,581

NOTES TO THE FINANCIAL STATEMENTS

1.	STATUTORY INFORMATION

SIGMA RESEARCH SOLUTIONS LTD is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

10838401

Registered office:

33 Blenheim Drive

Welling

DA16 3LY

2.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 1 (2020 - 2 ) .

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2021.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2021 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 14 March 2022 and were signed by:

V Priputnev - Director